[TYPO3-UG US] Case Study: Dana-Farber/Harvard Cancer Center

[Reuven Cohen, Enomaly]

> I'm not trying to buy Michelle's opinion but while I'm very happy with
> what Reuven had done with T3, I found it a bit too long and I lost 
> interest while reading. Nothing personal, it's just not punchy enough.

Thanks for all the great feed back. I'll take another stab at it.

1. Make it shorter
2. Make more compelling.
3. Introduce my company earlier

ruv